ConductScience.org, home

Trial · NCT00032630

Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass

NCT00032630, Phase 3, Completed, US Department of Veterans Affairs; results first posted 2014-01-10

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass. Trials, record NCT00032630. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00032630

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass
NCT number
NCT00032630
Status
Completed
Phases
Phase 3
Enrollment
2,203 participants, actual
Lead sponsor
US Department of Veterans Affairs
Conditions
Ischemic Heart Disease
Interventions
Coronary artery bypass - on-pump, Coronary artery bypass - off-pump
First posted
2002-03-28
Last updated
2014-05-05
Results first posted
2014-01-10

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryShort-term End Point30 day
Short-term end point was a composite of death or major complications (reoperation, new mechanical support, cardiac arrest, coma, stroke, or renal failure requiring dialysis) occuring within 30 days after surgery or before discharge, whichever was later.
PrimaryLong-term Compositeone-yearLong-term composite endpoint was death from any cause within 1 year, nonfatal myocardial infarction between 30 days and 1 year, or repeat revascularization between 30 days and 1 year.

Outcomes2

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYShort-term End Point30 dayparticipantsNUMBER
PRIMARYLong-term Compositeone-yearParticipantsNUMBER

Results by group4

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Short-term End PointOn Pump610.1 to 4.9participants
Short-term End PointOff Pump770.1 to 4.9participants
Long-term CompositeOn Pump78Participants
Long-term CompositeOff Pump105Participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDOn Pump1,099
Overall StudySTARTEDOff Pump1,104
Overall StudyCOMPLETEDOn Pump1,050
Overall StudyCOMPLETEDOff Pump1,061
Overall StudyNOT COMPLETEDOn Pump49
Overall StudyNOT COMPLETEDOff Pump43

Adverse events14

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
seriousChest PainCardiac disordersOn Pump641,09964
seriousChest PainCardiac disordersOff Pump691,10469
seriousCongestive Heart FailureCardiac disordersOn Pump331,09933
seriousCongestive Heart FailureCardiac disordersOff Pump301,10430
seriousPleural EffusionRespiratory, thoracic and mediastinal disordersOn Pump321,09932
seriousPleural EffusionRespiratory, thoracic and mediastinal disordersOff Pump301,10430
seriousMyocardial InfarctionCardiac disordersOn Pump181,09918
seriousMyocardial InfarctionCardiac disordersOff Pump361,10436
seriousCVANervous system disordersOn Pump191,09919
seriousCVANervous system disordersOff Pump191,10419

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityOn Pump
Total, all-cause mortalityOff Pump
Total, other adverse eventsOn Pump01,099
Total, other adverse eventsOff Pump01,104
Total, serious adverse eventsOn Pump2011,099
Total, serious adverse eventsOff Pump2201,104

Papers9

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
19890125RESULTPubMed
21130476DERIVEDPubMed
21978872DERIVEDPubMed
22592900DERIVEDPubMed
23916805RESULTPubMed
25442992DERIVEDPubMed
26470910DERIVEDPubMed
29653645DERIVEDPubMed
31001997DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons3

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
On Pump vs Off Pump: Short-term End PointTrial comparisons
On Pump vs Off Pump: Long-term CompositeTrial comparisons
On Pump vs Off Pump: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00032630

GET https://conductscience.org/api/trials/v1/NCT00032630/registered